Tag Archives: peripheral PCI


DEB, the Best Option to Treat Superficial Femoral ISR

DEB, the Best Option to Treat Superficial Femoral ISR

Original Title: Paclitaxel-eluting balloon versus standard balloon angioplasty in in-stent restenosis of the superficial femoral and proximal popliteal artery: 1-year results of the PACUBA trial. Reference: Kinstner CM et al. J Am Coll Cardiol Intv. 2016;9:1386-1392.   Patients with symptomatic femoropopliteal in-stent restenosis (ISR) have better patency at one year if treated with drug eluting


BVS: Safe Also in Peripheral Territory

Original Title: Bioresorbable Everolimus-Eluting Vascular Scaffold for Patients With Peripheral Artery Disease (ESPRIT I) 2-Year Clinical and Imaging Results CME. Reference: Johannes Lammer et al. J Am Coll Cardiol Intv. 2016;9(11):1178-1187.   This is the first study on humans to assess the bioresorbable everolimus eluting vascular scaffold for the treatment of peripheral artery disease involving


Zilver PTX: Maintains efficacy in real life most challenging lesions?

Original Title: Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan 12-Month Results. Reference: Hiroyoshi Yokoi et al. J Am Coll Cardiol Intv. 2016;9(3):271-277.   This multicenter prospective study carried out in Japan assessed the paclitaxel eluting stent Zilver PTX in an unselected real world population very different to

balón farmacológico

Drug coated balloons: Superior in infrapopliteal territory?

Original Title: Drug-Coated Balloons for Revascularization of Infrapopliteal Arteries. A Meta-Analysis of Randomized Trials. Reference: Salvatore Cassese et al. J Am Coll Cardiol Intv. 2016. Online before print.     The aim of this study was to perform a meta-analyzis of the most relevant randomized trials on the use of drug coated balloons (DCBs) in

Vorapaxar in Acute Limb Ischemia

Original Title: Acute Limb Ischemia and Outcomes With Vorapaxar in Patients with Peripheral Artery Disease: Results From TRA2°P-TIMI 50. Reference: Marc P. Bonaca et al. Circulation. 2016 Mar 8;133(10):997-1005.   Patients with peripheral artery disease have a high risk of acute limb ischemia, an event that may result in the loss of the affected limb. This

Femoropopliteal Artery Stent Thrombosis

Original Title: Femoropopliteal Artery Stent Thrombosis. Report from the Excellence in Peripheral Artery Disease Registry. Reference: Subhash Banerjee et al. Circ Cardiovasc Interv. 2016 Feb;9(2):e002730.   There is limited information on peripheral stent thrombosis and involved factors. This study analyzed 604 stent procedures in femoropopliteal territory form the multicenter registry “Excellence in Peripheral Artery Disease”. Stent

Beta Blockers Could Improve Outcomes in Carotid Artery Stenting

Original Title: Beta-blocker use is associated with lower stroke and death after carotid artery stenting. Reference: Tammman Obeid, et al. J Vasc. Surg. 2016;63:363-9. Courtesy of Dr. Carlos Fava. The latest trials on Carotid Artery Stenting (CAS) have shown significantly improved effectiveness. The use of drugs such as beta blockers (BB) have proved beneficial in some

Carotid stenting similar to surgery in asymptomatic patients

Original Title: Randomized Trial of stent versus Surgery for Asymptomatic Carotid Stenosis. Kenneth Rosenfield. N Engl J Med. 2016 Feb 17. [Epub ahead of print] Courtesy of Dr. Carlos Fava. Stokes are one of the main causes of death and disability in the world and up to 20% of strokes can be explained by carotid stenosis.

Bivalirudin could be beneficial in peripheral PCI

Original Title: Bivalirudin Is Associated with Improved In-Hospital Outcomes Compared with Heparin in Percutaneous Vascular Intervention. Observational, Propensity –Matched Analysis From the Premier Hospital Database.  Reference: Carey Kimmeslstiel, et al. Circ Cardiovasc Interv. 2016 Jan;9(1). Courtesy of Dr. Carlos Fava Lower limb vascular interventions are increasing in number and bleeding is one of its most

Intentando reducir la insuficiencia renal post TAVI

Hemodynamic Monitoring Optimization Reduces Kidney Injury in Carotid Stenting

Original title: Acute kidney Injury in Patients UIT Chronic Kidney Disease Undergoing Internal Carotid Artery Stent Implantation. Reference: Michael Donahue, et al J Am Coll Cardiol Interv 2015;8:1506-14 Post procedural acute kidney injury (AKI) in patients with chronic kidney disease has been associated with major events; however, the cause is still unclear. This study analyzed 126